Skip to content

Clinical trials

Phase 2 Vascular Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Vascular Diseases Phase: Phase 2 Country / region: Canada Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20141
20151
20181
20191
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Akcea Therapeutics1
Dr. Amer Johri1
Hemostemix1
Pulmovant, Inc.1
United Therapeutics1
University Health Network, Toronto1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Vascular Diseases6
Cardiovascular Diseases3
Heart Diseases2
Atherosclerosis1
Brain Diseases1
Brain Infarction1
Brain Ischemia1
Central Nervous System Diseases1
Cerebral Infarction1
Cerebrovascular Disorders1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.